Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer

International Journal of Cancer

Volumn 102, Issue 2, 2002, Pages 198-200

  Boks, Dominique E S ^a   Trujillo, Aliana P ^a   Voogd, Adri C ^b   Morreau, Hans ^a   Kenter, Gemma G ^a   Vasen, Hans F A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

Author keywords

Case control study; Endometrial carcinoma; Hereditary nonpolyposis colorectal cancer; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENDOMETRIUM CANCER; GENE MUTATION; GYNECOLOGIC CANCER; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; SURVIVAL RATE;

EID: 0037058298     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10667     Document Type: Article

References (24)

1. Sharma A, James M, Donaldson A, Fox R. Hereditary non-polyposis colorectal cancer syndrome: combined risk of gastrointestinal and gynaecological cancer. BJOG 2001;108:671-7.
2. Watson P, Vasen HF, Mecklin JP, Jarvinen H, Lynch HT. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994;96:516-20.
3. Platz CE, Benda JA. Female genital tract cancer. Cancer 1995;75(Suppl):270-94.
4. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 1974;2:122-9.
5. Rose PG. Endometrial carcinoma. NEJM 1996;335:640-9.
6. Boyd J. Estrogen as a carcinogen: the genetics and molecular biology of human endometrial carcinoma. Prog Clin Biol Res 1996;394:151-73.
7. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on 8. Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997;113:1146-58.
8. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
9. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in HNPCC syndrome. Int J Cancer 1995;64:430-3.
10. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, Bisgaard ML, Mohr J, Fodde R, Khan PM. Cancer risk in families with HNPCC diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
11. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.
12. Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, Taal BG, Moller P, Wijnen JT. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.
13. Watson P, Lin KM, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B, Karr B, Thorson A, Lynch HT. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998;83:259-66.
14. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-87.
15. Vasen HF, den Hartog Jager FC, Menko FH, Nagengast FM. Screening for HNPCC: a study of 22 kindreds in the Netherlands. Am J Med 1989;86:278-81.
16. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
17. Vasen HF. [Periodic examination of families with hereditary nonpolyposis colorectal carcinoma in The Netherlands: a study of 41 families] Ned Tijdschr Geneeskd. 1994;138:77-81.
18. Myrhoj T, Bisgaard ML, Bernstein I, Svendsen LB, Sondergaard JO, Bulow S. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol 1997;32:572-6.
19. Parc YR, Halling KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN, Halling AC. Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology. Int J Cancer 2000;86:60-6.
20. Creasman WT. Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. Semin Oncol 1997;24(1 Suppl 1):SI-140-SI-50.
21. Hakala T, Mecklin JP, Forss M, Jarvinen H, Lehtovirta P. Endometrial carcinoma in the cancer family syndrome. Cancer 1991;68:1656-9.
22. Sumoi R, Hakala-Ala-Pietila T, Leminen A, Mecklin JP, Lehtovirta P. Hereditary aspects of endometrial adenocarcinoma. Int J Cancer 1995;62:132-7.
23. Gruber SB, Thompson WD. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. Cancer Epidemiol Biomarkers Prev 1996;5:411-7.
24. Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ, Voogd AC (eds). Cancer incidence and survival in the South of the Netherlands, 1955-1999 and incidence in the north of Belgium 1996-1998. Eindhoven: Comprehensive Cancer Centre South (IKZ), 2001.